Source: Reuters
Posted: May 17, 2007 1:16PM EDT
Summary:
Geron Corporation reported it successfully turned human embryonic stem cells into the pancreatic cells that produce insulin, an advancement that may lead to a treatment for diabetes. The company collaborated with Canadian researchers who have specialized in a transplant technique called the Edmonton Protocol, which as been shown to restore insulin-producing cells in patients with type-1 diabetes. Researchers believe the finding, published in the journal Stem Cells, might provide evidence of one of the most sought-after functions of embryonic stem cells -- treating diabetes.
